FORXIGA 10 mg, film-coated tablet 30 tablets
Active ingredients: DAPAGLIFLOZINE, Dapagliflozin propanediol hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FORXIGA 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- ASTRAZENECA AB
- Reimbursement according to BDPM
- 65 %
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Diabète gras (dit "de type 2"), en association avec un ou deux autres médicaments antidiabétiques précisément définis. ; JOURNAL OFFICIEL ; 01/04/20
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Apr 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67456363CIP72664997CIP133400926649975Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉcomprimé | 12,30 mg · un comprimé | SA |
| DAPAGLIFLOZINEcomprimé | 10 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.